A positive correlation between hemoglobin and FGF19 in HCC patients 24 h post-transplant, which we do not observe in other diseases, may be due to the unique metabolic needs and the body’s specific response to liver regeneration in the context of prior cancer [30,45,51]. This evidence concerns the gene FGF19 and hepatocellular carcinoma.